12:31 EDT Phathom jumps 124% to $10.49 after FDA corrects Voquenza exclusivity
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Largest borrow rate increases among liquid names
- Biotech Alert: Searches spiking for these stocks today
- Phathom Pharmaceuticals price target lowered to $12 from $18 at Guggenheim
- Phathom Pharmaceuticals price target lowered to $20 from $28 at H.C. Wainwright
- Phathom Pharmaceuticals Reports Q1 2025 Financial Results
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue